Skip to main content

Howard Scher, MD

Howard Scher, MD

Senior Advisor

Areas of Focus:

  • BioPharma and Life Sciences

Prior Experience:

  • Memorial Sloan-Kettering Cancer Center
    Chief, Genitourinary Oncology Service; D. Wayne Calloway Chair in Urologic Oncology
  • Memorial Sloan Kettering Prostate Cancer SPORE
    Principle Investigator
  • Weill Cornell Medical College 
    D. Wayne Calloway Chair in Urologic Oncology and Professor of Medicine
  • Department of Defense Prostate Cancer Research Program
    Principle Investigator
  • Prostate Cancer Foundation
    Researcher

Boards:

  • WIRB - Copernicus Group Oncology and Gene Therapy Advisory Boards
  • Asterias Biotherapeutics, Inc. Board of Directors
  • ProstaGene, LLC Clinical Advisory Board
  • CytRx Oncology Corporation Advisory Board
  • Chairman of the Scientific Oversight Committee at The Prostate Cancer Clinical Trials Consortium
  • Reviewer of The New England Journal of Medicine, Nature, Science and Translational Medicine, Lancet Oncology, and the Journal of Clinical Oncology
  • ProQuest Investments Scientific Advisory Board
  • ProQuest Investments Advisory Board
  • INNOVIVE Pharmaceuticals Scientific Advisory Board (Previous)
  • Genta Inc. Scientific Advisory Board (Previous) 
  • Cougar Biotechnology, Inc. Scientific Advisory Board (Previous)
  • Ambrilia Biopharma, Inc Scientific Advisory Board (Previous)
  • Conforma Therapeutics Corporation Scientific Advisory Board (Previous)

Education:

  • M.D.
    New York University School of Medicine
  • B.S. 
    Bates College